MicroRNA‐351‐5p aggravates intestinal ischaemia/reperfusion injury through the targeting of MAPK13 and Sirtuin‐6
Authors:
- 27 June 2018
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (17) , 3594-3609
Abstract
Background and Purpose: Intestinal ischaemia‐reperfusion (II/R) injury is a serious clinical problem. Here we have investigated novel mechanisms and new drug targets in II/R injury by searching for microRNAs regulating such injury.Experimental Approach: We used hypoxia/reoxygenation (H/R) of IEC‐6 cell cultures and models of II/R models in rats and mice. Microarray assays were used to identify target miRNAs from rat intestinal. Real‐time PCR, Western blot and dual luciferase reporter assays, and agomir and antagomir in vitro and in vivo were used to assess the effects of the target miRNA on II/R injury.Key Results: The miR‐351‐5p was differentially expressed in our models and it targeted MAPK13 and sirtuin‐6. This miRNA reduced levels of sirtuin‐6 and AMP‐activated protein kinase phosphorylation, and activated forkhead box O3 (FoxO3α) phosphorylation to cause oxidative stress. Also, miR‐351‐5p markedly reduced MAPK13 level, activated polycystic kidney disease 1/NF‐κB signal and increased NF‐κB (p65). Moreover, miR‐351‐5p up‐regulated levels of Bcl2‐associated X, cytochrome c, apoptotic peptidase activating factor 1, cleaved‐caspase 3 and cleaved‐caspase 9 by reducing sirtuin‐6 levels to promote apoptosis. In addition, miR‐351‐5p mimic in IEC‐6 cells and agomir in mice aggravated these effects, and miR‐351‐5p inhibitor and antagomir in mice alleviated these actions.Conclusions and Implications: Our data showed that miR‐351‐5p aggravated II/R injury by promoting intestinal mucosal oxidative stress, inflammation and apoptosis by targeting MAPK13 and sirtuin‐6.These data provide new insights into the mechanisms regulating II/R injury, and of miR‐351‐5p could be considered as a novel therapeutic target for such injury.Keywords
Funding Information
- the Science and Technology Innovation Fund of Dalian, China (81603178)
- Special Grant for Translational Medicine, Dalian Medical University (2015004)
- Project of Liaoning BaiQianWan Talents Program (2015-65)
- Key Research and Development Project of Liaoning Province (2017225090)
This publication has 46 references indexed in Scilit:
- Protective Effect of Ginsenoside Rb1 Against Lung Injury Induced by Intestinal Ischemia-Reperfusion in RatsMolecules, 2013
- IL-13–induced airway mucus production is attenuated by MAPK13 inhibitionJournal of Clinical Investigation, 2012
- MicroRNA‐146a‐mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injuryEMBO Molecular Medicine, 2012
- Regulation of PTEN activity by p38δ-PKD1 signaling in neutrophils confers inflammatory responses in the lungJournal of Experimental Medicine, 2012
- p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activationProceedings of the National Academy of Sciences, 2012
- Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusionMolecular Immunology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- PKD prevents H2O2-induced apoptosis via NF-κB and p38 MAPK in RIE-1 cellsBiochemical and Biophysical Research Communications, 2009
- T1299 Ischemia-Reperfusion Injury in Small Intestine Is Mediated By Toll-Like Receptor 2Gastroenterology, 2008
- Prophylactic Use of Epidermal Growth Factor Reduces Ischemia/Reperfusion Intestinal DamageThe American Journal of Pathology, 2002